In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Xeotron Corp.

Division of Thermo Fisher Scientific Inc.

Latest From Xeotron Corp.

Start-Up Previews (12/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Specialty Pharmaceuticals, features profiles of Advancis Pharmaceutical Corp., Avera Pharmaceuticals Inc., ESP Pharma Inc. and Ovation Pharmaceuticals Inc. Plus these Start-Ups across Health Care: Advanced Bio Prosthetic Surfaces Ltd., Aton Pharma Inc., Kerberos Proximal Solutions Inc. and Xeotron Corp.

Xeotron Corp.

Xeotron Corp. employs light activation, digital photolithography, and parallel microfluidics in its biochip making process. The company claims that its flexible platform technology will produce DNA, protein and peptide chips at a faster rate and lower cost than its competitors.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Thermo Fisher Scientific Inc.
  • Senior Management
  • Tim McGrath, CEO
    Xiaochuan Zhou, Pres. & CTO
    David Sun, VP, Bus. Dev. & Mktg.
  • Contact Info
  • Xeotron Corp.
    Phone: (713) 842-2121
    8275 El Rio
    Ste. 130
    Houston, TX 77054